Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes. - Wikidata - awgldk - TriplyDB

Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.

Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.

http://www.wikidata.org/entity/Q37043504

about

Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy.Clinical use of lentiviral vectors.A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model.Viral Vectors in Gene Therapy.

P2860

Q38739432-0C970D2C-9BE2-4709-A32C-2833A6105D47 Q39260698-754BD418-DB6D-40D0-A423-04F9743217E1 Q45873930-B301324D-47D6-4681-A289-DAFEBA6C627E Q45874789-B264BD0E-9DCC-45E6-92FC-25180E0FE267 Q52589095-11A0363D-E4EF-4BFE-9B59-E19B64C19AE9 Q54940529-24DF0E1E-646E-4615-A6DF-529A7391741E Q55408780-7CE95FC5-D08B-4222-A643-7A8ED7D7F0A3

P2860

Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.

http://www.wikidata.org/entity/Q37043504

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evaluating the Safety of Retro ...... iation in Cultured Thymocytes.

@en

Evaluating the Safety of Retro ...... iation in Cultured Thymocytes.

@nl

type

label

Evaluating the Safety of Retro ...... iation in Cultured Thymocytes.

@en

Evaluating the Safety of Retro ...... iation in Cultured Thymocytes.

@nl

prefLabel

Evaluating the Safety of Retro ...... iation in Cultured Thymocytes.

@en

Evaluating the Safety of Retro ...... iation in Cultured Thymocytes.

@nl

P1433

Q37043504-A0B12D37-86B9-4EC3-A5DC-8A0CC099F18A

P1476

Q37043504-854D24E0-6F0A-474A-9089-FCA725C4EB25

P2093

Q37043504-11A28BA9-98F8-4D0F-A270-04ADAB6A89F5

Q37043504-12C13D0D-D573-4C1D-9003-693E7DB0307C

Q37043504-1F7A71BF-B884-4ADC-B22F-D463D5DBA872

Q37043504-465BBD79-56B6-4C4B-A2C0-A2B89CCB8451

Q37043504-6F3C700C-D730-415D-BE0A-ABB7F02BB358

Q37043504-9CBEE40B-63E4-42E3-8A7B-58564D2EB6DB

Q37043504-AAE8B811-C7D4-4E26-AEF8-DA334B6DCCBA

Q37043504-F87B1E62-4D3A-4FA0-9513-C554ADE2CB7A

P2860

Q37043504-00229F07-FDCB-46BB-A68A-89B95530C966

Q37043504-04BE6E30-113B-4BDE-9F33-154B06A70649

Q37043504-05A51CC3-6D67-42AE-9542-C60ED822DE52

Q37043504-05F32BC1-A447-4CC2-B424-98EFD47C44AE

Q37043504-07BD94F5-6ED4-4327-B919-FD378B6BEE21

Q37043504-0BDD0827-B8BF-4B8B-AB94-086DAC5C35C2

Q37043504-0CFF3D01-3CE2-40A0-BFA1-551DECF03992

Q37043504-0D67C56B-E3BC-4668-A55B-FA006E05BE8C

Q37043504-14BCA861-E1DA-41B0-9697-680AF5A962BA

Q37043504-1D3A20FA-6843-4EA3-A1E8-89749690DBEA

P304

Q37043504-B01E0594-FB54-4A5D-B78F-BD363113DF82

P31

Q37043504-0E9EECA7-48B2-4334-8B46-459EAA6B55C9

P356

Q37043504-4360752E-BC4B-49FA-9872-1D318545BDD5

P433

Q37043504-15D7C8DE-D9F3-4AB9-A44A-6504891C6996

P478

Q37043504-8FD64BDD-C36B-4157-8D7F-B905A018E6F1

P577

Q37043504-2A52D526-0BFD-4BAB-957A-78763D9028A7

P5875

Q37043504-3576C3D8-1706-4CB7-AAD3-8661801F38DE

P698

Q37043504-A28D16E1-E47E-485D-89F4-9963E082CB53

P932

Q37043504-7E992CB6-7098-408A-988A-A5EB407051D1

P356

P1433

Molecular Therapy

P1476

Evaluating the Safety of Retro ...... iation in Cultured Thymocytes.

@en

P2093

Brian P Sorrentino

http://www.w3.org/2001/XMLSchema#string

Laura J Janke

http://www.w3.org/2001/XMLSchema#string

Sheng Zhou

http://www.w3.org/2001/XMLSchema#string

Soghra Fatima

http://www.w3.org/2001/XMLSchema#string

Taihe Lu

http://www.w3.org/2001/XMLSchema#string

Yang Du

http://www.w3.org/2001/XMLSchema#string

Yong-Dong Wang

http://www.w3.org/2001/XMLSchema#string

Zhijun Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis

Charting a clear path: the ASGCT Standardized Pathways Conference

Enhancers are major targets for murine leukemia virus vector integration

Comparison of insulators and promoters for expression of the Wiskott-Aldrich syndrome protein using lentiviral vectors.

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

The 3' region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity.

P304

1090-1099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2016.55

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297729830

http://www.w3.org/2001/XMLSchema#string

P698

26957223

http://www.w3.org/2001/XMLSchema#string

P932

4923324

http://www.w3.org/2001/XMLSchema#string